Sentinel lymphadenectomy for breast cancer: Experience with 180 consecutive patients: Efficacy of filtered technetium 99m sulphur colloid with overnight migration time

Journal of the American College of Surgeons

Volumn 188, Issue 6, 1999, Pages 597-603

  Winchester, David J ^a,c   Sener, Stephen F ^a,b,c   Winchester, David P ^a,c   Perlman, Reid M ^b,c   Goldschmidt, Robert A ^a,c   Motykie, Gary ^a,c   Martz, Carole H ^a,c   Rabbitt, Sarah L ^a,c   Brenin, David ^a,c   Stull, Margaret A ^b,c   Moulthrop, Jeanette M ^b,c  

^a Evanston Northwestern Healthcare ^*  (United States)

^b EVANSTON NORTHWESTERN HEALTHCARE   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TECHNETIUM SULFUR COLLOID TC 99M;

ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER CONTROL; CANCER RECURRENCE; CANCER SURVIVAL; FEMALE; HUMAN; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SURGICAL TECHNIQUE; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR LOCALIZATION;

AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SULFUR COLLOID;

EID: 0033023798     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1072-7515(99)00060-5     Document Type: Article

References (16)

1. Danforth DN. The role of axillary lymph node dissection in the management of breast cancer. Principles and Practice of Oncolgoy Updates, vol. 6(2), Philadelphia: JB Lippincott; 1992.
2. Cabanas R. An approach for the treatment of penile carcinoma. Cancer 1977;39:456-466.
3. Morton DL, Wen D-R, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-399.
4. Fisher B, Redmond C, Fisher ER, et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 1985;312: 674-681.
5. Giuliano AE, Jones RC, Brennan M, Statman R. Sentinel lymph-adenectomy in breast cancer. J Clin Oncol 1997;15(6):2345-2350.
6. Veronesi U, Paganelli G, Galimberti V, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes. Lancet 1197;349:1864-1867.
7. Albertini JJ, Lyman GH, Cox C, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996;276:1818-1822.
8. Cox CE, Pendas S, Cox JM, et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 1998;227:645-653.
9. Krag D, Weaver D, Ashikaga T, et al. The sentinel in breast cancer. A multicenter validation study. N Engl J Med 1998; 339:941-946.
10. Offodile R, Hoh C, Barsky SH, et al. Minimally invasive breast cancer staging using lymphatic mapping with radiolabeled dextran. Cancer 1998;82:1704-1708.
11. Borgstein PJ, Pijpers R, Comans EF, et al. Sentinel lymph node in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 1998;186:275-283.
12. Guenther JM, Krishnamoorthy M, Tan LR. Sentinel lymphadenectomy for breast cancer in a community managed care setting. Cancer J Sci Am 1997;3:336-340.
13. O'Hea BJ, Hill ADK, El-Shirbiny AM, et al. Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg 1998;186: 423-427.
14. International (Ludwig) Breast Cancer Study Group. Prognostic importance of occult axillary lymph node micrometastases from breast cancers. Lancet 1990;335:1565-1568.
15. Clare SE, Sener SF, Wilkens W, et al. Prognostic significance of occult lymph node metastases in node-negative breast cancer. Ann Surg Oncol 1997;4(6):447-451.
16. th ed, Philadelphia: Lippincott-Raven; 1997:174.